Follow-The-Filings

Security · featured owners

AGL Agilon Health Inc.

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.5%
  • $47M
  • 1 new

AGL (Agilon Health Inc.) is held in 1 featured 13F book as of 2026 Q2. Henry Ellenbogen - Durable Capital Partners is the largest tracked holder by portfolio weight (0.46%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.5% (Henry Ellenbogen - Durable Capital Partners) · not free-float ownership

  1. Henry Ellenbogen New 0.46%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Henry Ellenbogen - Durable Capital Partners 2026 Q2 0.46% New 0.46% 440,642 $47M History

1 current · options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
8-K 3.03,5.03,9.01 Filing Doc
8-K 5.07,8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
DEFA14A Filing Doc
8-K 1.01,2.03,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Aug 16, 2026 Filing Doc
4 Period Aug 1, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period Jun 2, 2026 · 6 forms Filing Doc
4 Period May 24, 2026 Filing Doc
4 Period May 7, 2026 Filing Doc
4 Period Apr 14, 2026 · 4 forms Filing Doc
4 Period Apr 1, 2026 · 5 forms Filing Doc
4 Period Mar 9, 2026 · 3 forms Filing Doc
4 Period Mar 2, 2026 Filing Doc

Updated 21 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $4.32B $6.06B $5.93B
Net income -$262.6M -$260.15M -$391.35M
Net margin * -6.1% -4.3% -6.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.48B $1.46B $1.1B
Total non-current assets * $260.79M $276.21M $174.59M
Total assets $1.74B $1.73B $1.27B
Total current liabilities $0.977B $1.15B $1.08B
Total non-current liabilities * $102.69M $111.02M $68.07M
Total equity $661.84M $470.95M —

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$156.2M -$57.78M -$105.76M
Cash from investing -$44.02M $139.89M $88.61M
Cash from financing -$193.13M -$2.58M -$2.99M
Net change in cash * -$393.35M $79.53M -$20.15M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders

Q2 2026

Period archive